Could clazosentan, first approved in Japan, improve neurological prognosis after subarachnoid hemorrhage in combination with modified water-electrolyte management?
- Resource Type
- Review Article
- Source
- In
Brain Hemorrhages April 2024 5(2):91-97 - Subject
- Language
- ISSN
- 2589-238X